BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30053706)

  • 1. Difficulties in emotion regulation and chronic pain-related disability and opioid misuse.
    Lutz J; Gross RT; Vargovich AM
    Addict Behav; 2018 Dec; 87():200-205. PubMed ID: 30053706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting aberrant opioid behavior in the emergency department: a prospective study using the screener and Opioid Assessment for Patients with Pain-Revised (SOAPP
    Varney SM; Perez CA; Araña AA; Carey KR; Ganem VJ; Zarzabal LA; Ramos RG; Bebarta VS
    Intern Emerg Med; 2018 Dec; 13(8):1239-1247. PubMed ID: 29502329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pain Experiences and Their Relation to Opioid Misuse Risk and Emotion Dysregulation.
    Nauser JW; Nelson CI; Gross RT; Vargovich AM
    Pain Res Manag; 2020; 2020():7234625. PubMed ID: 33224363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Risk for Opioid Misuse in Chronic Pain with a Single-Item Measure of Catastrophic Thinking.
    Lutz J; Gross R; Long D; Cox S
    J Am Board Fam Med; 2017; 30(6):828-831. PubMed ID: 29180559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk stratification of opioid misuse among patients with cancer pain using the SOAPP-SF.
    Koyyalagunta D; Bruera E; Aigner C; Nusrat H; Driver L; Novy D
    Pain Med; 2013 May; 14(5):667-75. PubMed ID: 23631401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Brief Version of the Current Opioid Misuse Measure (COMM): The COMM-9.
    McCaffrey SA; Black RA; Villapiano AJ; Jamison RN; Butler SF
    Pain Med; 2019 Jan; 20(1):113-118. PubMed ID: 29237039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficits in autonomic indices of emotion regulation and reward processing associated with prescription opioid use and misuse.
    Garland EL; Bryan CJ; Nakamura Y; Froeliger B; Howard MO
    Psychopharmacology (Berl); 2017 Feb; 234(4):621-629. PubMed ID: 27933366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of an Eight-Item Brief Form of the SOAPP-R (SOAPP-8).
    Black RA; McCaffrey SA; Villapiano AJ; Jamison RN; Butler SF
    Pain Med; 2018 Oct; 19(10):1982-1987. PubMed ID: 29024987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R).
    Butler SF; Fernandez K; Benoit C; Budman SH; Jamison RN
    J Pain; 2008 Apr; 9(4):360-72. PubMed ID: 18203666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain.
    Wasan AD; Butler SF; Budman SH; Benoit C; Fernandez K; Jamison RN
    Clin J Pain; 2007 May; 23(4):307-15. PubMed ID: 17449991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Short-Form Versions of the Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R): A Proof-of-Principle Study.
    Finkelman MD; Smits N; Kulich RJ; Zacharoff KL; Magnuson BE; Chang H; Dong J; Butler SF
    Pain Med; 2017 Jul; 18(7):1292-1302. PubMed ID: 27605589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated pain sensitivity in chronic pain patients at risk for opioid misuse.
    Edwards RR; Wasan AD; Michna E; Greenbaum S; Ross E; Jamison RN
    J Pain; 2011 Sep; 12(9):953-63. PubMed ID: 21680252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anhedonia in chronic pain and prescription opioid misuse.
    Garland EL; Trøstheim M; Eikemo M; Ernst G; Leknes S
    Psychol Med; 2020 Sep; 50(12):1977-1988. PubMed ID: 31422776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between severity of depression and prescription opioid misuse among chronic pain patients with and without anxiety: A cross-sectional study.
    Feingold D; Brill S; Goor-Aryeh I; Delayahu Y; Lev-Ran S
    J Affect Disord; 2018 Aug; 235():293-302. PubMed ID: 29660645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catastrophic thinking and increased risk for prescription opioid misuse in patients with chronic pain.
    Martel MO; Wasan AD; Jamison RN; Edwards RR
    Drug Alcohol Depend; 2013 Sep; 132(1-2):335-41. PubMed ID: 23618767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Contribution of Differential Opioid Responsiveness to Identification of Opioid Risk in Chronic Pain Patients.
    Bruehl S; Burns JW; Passik SD; Gupta R; Buvanendran A; Chont M; Schuster E; Orlowska D; France CR
    J Pain; 2015 Jul; 16(7):666-75. PubMed ID: 25892658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spanish translation and linguistic validation of the screener and opioid assessment for patients with pain-revised (SOAPP-R).
    Butler SF; Zacharoff KL; Budman SH; Jamison RN; Black R; Dawsey R; Ondarza A
    Pain Med; 2013 Jul; 14(7):1032-8. PubMed ID: 23590454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dispositional mindfulness and prescription opioid misuse among chronic pain patients: Craving and attention to positive information as mediating mechanisms.
    Priddy SE; Hanley AW; Riquino MR; Platt KA; Baker AK; Garland EL
    Drug Alcohol Depend; 2018 Jul; 188():86-93. PubMed ID: 29754031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adapting the Current Opioid Misuse Measure (COMM) for people with chronic pain and disability due to arthritis: The development of the COMM 11-PWDA.
    Mallery Lankford C; Paez K; Yang M; Lin A
    Disabil Health J; 2022 Jun; 15(2S):101296. PubMed ID: 35414483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for current opioid misuse and associated risk factors among patients with chronic nonalcoholic pancreatitis pain.
    Barth KS; Balliet W; Pelic CM; Madan A; Malcolm R; Adams D; Morgan K; Owczarski S; Borckardt JJ
    Pain Med; 2014 Aug; 15(8):1359-64. PubMed ID: 24716629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.